June 17, 2015
Inspire Pharmaceuticals Inc. agreed to pay $5.9 million to settle a False Claims Act suit accusing the former unit of Merck & Co. Inc. of fraudulently marketing a drug used to treat pinkeye for off-label use, federal prosecutors said Wednesday.